Ghana Business News API

{
    "totalArticles": 14326,
    "articles": [
        {
            "id": "9b5c7e256c399ec563c8aa164e9dafc8",
            "title": "Bank of England to announce interest rate decision",
            "description": "Mortgages, loans and savings will all be impacted by the interest rate announcement.",
            "content": "What has happened to UK interest rates and inflation?\nThe Bank of England's base rate reached a recent high of 5.25% in 2023.\nIt remained at that level until August 2024, when the Bank started cutting.\nFive cuts brought rates down to 4%, before the B... [4701 chars]",
            "url": "https://www.bbc.com/news/live/cm2r295p8p9t",
            "image": "https://static.files.bbci.co.uk/core/website/assets/static/news/images/metadata/poster-1024x576.5f404a8b8b.png",
            "publishedAt": "2026-03-19T11:26:14Z",
            "lang": "en",
            "source": {
                "id": "f331a5ed3965fb59761dfcecfc7e7a34",
                "name": "BBC",
                "url": "https://www.bbc.com"
            }
        },
        {
            "id": "f39a692d48bb48bed5103f34660acf2c",
            "title": "Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes",
            "description": "The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.",
            "content": "For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1\nParticipants taking retatrutide 12 mg lost an average of 36.6 lbs (16.8%)\nNo weight loss plateau was observed with retatrutide... [9650 chars]",
            "url": "https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-demonstrated-significant",
            "image": "https://investor.lilly.com/static-files/414b590d-5fd8-4d74-bb91-284a3d77fb98",
            "publishedAt": "2026-03-19T10:48:27Z",
            "lang": "en",
            "source": {
                "id": "5ef52989243f0eb934954fd37ad8041a",
                "name": "Eli Lilly",
                "url": "https://investor.lilly.com"
            }
        },
        {
            "id": "c1795be6efdb6361eed02accb13bef77",
            "title": "Telefónica Tech is forging key partnerships to bring quantum computing to real-world AI applications",
            "description": "Telefónica Tech announces a partnership with Qilimanjaro Quantum Tech, QCentroid and Multiverse Computing to offer a comprehensive quantum AI.",
            "content": "Telefónica Tech today announced a partnership with three new strategic partners (Qilimanjaro Quantum Tech, QCentroid and Multiverse Computing) to further develop its comprehensive offering in quantum computing and its integration with advanced artifi... [2419 chars]",
            "url": "https://www.telefonica.com/en/communication-room/press-room/telefonica-tech-forging-key-partnerships-bring-quantum-computing-real-world-ai-applications/",
            "image": "https://www.telefonica.com/wp-content/themes/telefonica-theme/img/png/favicon-DE.png",
            "publishedAt": "2026-03-19T10:40:25Z",
            "lang": "en",
            "source": {
                "id": "81982293c51f6f843c5d98fc45579a96",
                "name": "telefonica.com",
                "url": "https://www.telefonica.com"
            }
        }
    ]
}